LDD-24418-58388
3 vaccinations
2 coded responses
30 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 857 / AZ
- Registered
- 2022-08-02
- Relationship
- Child or adolescent in my care
- Guardian
- WLW-27131-48058
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-08-01
Dose 1 — Pfizer-BioNTechCo-administered: MMR:Tetanus
-
2022-08-02
Registered in v-safe
- 2022-08-02
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-07
- 2022-08-08
- 2022-08-15
- 2022-08-22
-
2022-08-24
Dose 2 — Pfizer-BioNTech
- 2022-08-26
- 2022-08-27
- 2022-08-28
- 2022-08-29
- 2022-08-30
- 2022-08-31
- 2022-09-09
-
2022-09-14
Survey response — day 21, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Seems like a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-09-21
- 2022-09-28
- 2022-10-05
-
2022-10-19
Dose 3 — Pfizer-BioNTech
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-11-02
- 2022-11-11
- 2022-11-16
- 2022-11-23
-
2023-01-18
Survey response — 3 months, dose 3, under 3MedDRA: Asthma, Bronchial secretion retention — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-18
Report sent to call center — 3 months, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-01 | Pfizer-BioNTech | MMR:Tetanus |
| 2 | 2022-08-24 | Pfizer-BioNTech | No |
| 3 | 2022-10-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-18 | Unsuccessful |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Seems like a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Bronchial secretion retention | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release